Geneva, July 7 -- International Clinical Trials Registry received information related to the study (NCT07667400) titled 'Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer' on June 24.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: National Cancer Institute (NCI)
Condition:
Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma
Paranasal Sinus Neoplasms
Nasopharyngeal Carcinoma
Oropharyngeal Squamous Cell Carcinoma
Hypopharyngeal Cancer
Carcinoma of Larynx
Oral Squamous Cell Carcinoma
Salivary Gland Cancer...